This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Glazier AM et al. Science 2003; 298: 2345–2349.
Nadeau JH . Nat Rev Genet 2001; 2: 165–174.
Darvasi A, Pisante-SShalom A . Trends Genet 2002; 18: 489–491.
Charron P, Komajda M . Pharmacogenomics 2002; 3: 367–378.
McNamara DM et al. Circulation 2003; 107: 1598–1602.
Small KM et al. New Engl J Med 2002; 347: 1135–1142.
Grzeskowiak R et al. Cardiovasc Res 2003; 59: 400–411.
Dos Remedios CG et al. J Muscle Res Cell Motil 2003; 24: 251–260.
Chu G et al. J Card Fail 2002; 8(Suppl): S432–S449.
Fatkin D et al. N Engl J Med 1999; 341: 1715–1724.
Le Corvoisier P et al. Hum Mol Genet 2003; 12: 3097–3107.
Harding VB et al. Proc Natl Acad Sci USA 2001; 98: 5809–5814.
Suziki M et al. Circulation 2002; 105: 1824–1829.
Rapp JP . Physiol Rev 2000; 80: 135–172.
Author information
Authors and Affiliations
Corresponding author
Additional information
DUALITY OF INTEREST
None declared.
Rights and permissions
About this article
Cite this article
Komajda, M., Charron, P. A new approach for the identification of modifier genes in heart failure. Pharmacogenomics J 4, 221–223 (2004). https://doi.org/10.1038/sj.tpj.6500257
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500257
This article is cited by
-
Identifying modifier genes of monogenic disease: strategies and difficulties
Human Genetics (2008)